Pharmacie by Medi-Market Group - Korbeek-Lo
0821.789.344 · rovalta.com · 28/09/2026
Pharmacie by Medi-Market Group - Korbeek-Lo
Company — Normal situation.
Strike-off: 25 juin 2026
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPharmacie by Medi-Market Group - Korbeek-Lo is a Private limited company incorporated in 2009.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0821.789.344
- Incorporation
- 17/12/2009
- Legal form
- Private limited company
- Contributed capital
- 6 200,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 0,0 ETP
Financials
Source · NBB, 16 filingsTrend over 16 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 9,1 k € | +43.6% | 6,4 k € | +9.0% | 5,8 k € | -86.5% | 43,3 k € | +48.6% | 29,2 k € |
| EBITDA | 8,5 k € | +62.1% | 5,2 k € | -3.7% | 5,4 k € | -87.1% | 42,2 k € | +47.8% | 28,6 k € |
| Operating result | 8,5 k € | +62.4% | 5,2 k € | -3.7% | 5,4 k € | -87.1% | 42,2 k € | +47.8% | 28,6 k € |
| Net result | 13,2 k € | +59.1% | 8,3 k € | +491% | -2,1 k € | -106% | 38,1 k € | +33.5% | 28,6 k € |
| Balance sheet | |||||||||
| Equity | 145,7 k € | +10.0% | 132,5 k € | +6.7% | 124,2 k € | -1.7% | 126,3 k € | +43.2% | 88,2 k € |
| Total assets | 298,3 k € | +33.0% | 224,3 k € | +12.5% | 199,3 k € | +49.4% | 133,4 k € | +21.8% | 109,6 k € |
| Cash | 0 € | -100% | 1,3 k € | -0.9% | 1,3 k € | +93.1% | 675,5 € | +29.4% | 521,9 € |
| Debts | 152,7 k € | +66.3% | 91,8 k € | +22.2% | 75,1 k € | +959% | 7,1 k € | -66.8% | 21,4 k € |
| Other | |||||||||
| Workforce | 0,0 ETP | 0,0 ETP | 0,0 ETP | 0,0 ETP | – | ||||
Board of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 01/06/2021 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Yvan Verougstraete | Director01/10/2018 → 30/06/2021Managersince 01/10/2018 | ||
Ann Baeck | Manager17/12/2009 → 01/01/2019 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 01/07/2026 | 10/07/2025 | 23/07/2024 | 28/08/2023 | 30/03/2023 | 06/04/2022 |
| General meeting | 29/06/2026 | 27/06/2025 | 01/07/2024 | 25/08/2023 | 30/03/2023 | 28/03/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 16 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 29/06/2026 | 01/07/2026 | French | |
| Abridged model | 31/12/2024 | 27/06/2025 | 10/07/2025 | French | |
| Abridged model | 31/12/2023 | 01/07/2024 | 23/07/2024 | French | |
| Abridged model | 31/12/2022 | 25/08/2023 | 28/08/2023 | French | |
| Abridged model | 31/12/2021 | 30/03/2023 | 30/03/2023 | French | |
| Abridged model | 31/12/2020 | 28/03/2022 | 06/04/2022 | French | |
| Abridged model | 31/12/2019 | 18/12/2020 | 18/12/2020 | French | |
| Abridged model | 31/12/2018 | 31/05/2019 | 28/06/2019 | Dutch | |
| Abridged model | 31/12/2017 | 25/05/2018 | 18/06/2018 | Dutch | |
| Abridged model | 31/12/2016 | 26/05/2017 | 26/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 27/05/2016 | 27/05/2016 | Dutch | |
| Abridged model | 31/12/2014 | 29/05/2015 | 06/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 30/05/2014 | 28/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 31/05/2013 | 18/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 25/05/2012 | 24/08/2012 | Dutch | |
| Abridged model | 31/12/2010 | 27/05/2011 | 30/08/2011 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 01/06/2021 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Yvan Verougstraete | Director01/10/2018 → 30/06/2021Managersince 01/10/2018 | ||
Ann Baeck | Manager17/12/2009 → 01/01/2019 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Restructuring02/07/2026ASSEMBLEE GENERALE EXTRAORDINAIRE - Fusion par absorption
- Restructuring07/05/2026Projet de fusion - Pouvoirs
- Other14/10/2025Renouvellement du mandat du commisaire - Pouvoirs
- Mandates05/06/2024MODIFICATION FORME JURIDIQUE, DEMISSIONS,
- Mandates06/02/2023DEMISSIONS, NOMINATIONS
- Mandates30/06/2021DEMISSIONS, NOMINATIONS
- Mandates04/02/2020ONTSLAGEN - BENOEMINGEN
- Mandates29/03/2019MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Avenue Cicéron 7, 1140 Evere | CBE until 25/06/2026 | CBE |
| Avenue Cicéron 7, 1140 Evere | accounts 2020 → 2025 | Accounts 2025 · 2026-00244155 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Pharmacie by Medi-Market Group - Korbeek-Lo | CBE until 25/06/2026 | CBE |
| Pharmacie by Medi-Market Group - Korbeek-Lo | accounts 2023 → 2025 | Accounts 2025 · 2026-00244155 |
| Apotheek Baeck | accounts 2010 → 2022 | Accounts 2022 · 2023-00409350 |
Events
- 2025Annual accounts 202513,2 k €↑
- 2024Annual accounts 20248,3 k €↑
- 2023Annual accounts 2023-2,1 k €↓
- 2023Name changePharmacie by Medi-Market Group - Korbeek-Lo
- 2022Annual accounts 202238,1 k €↑
- 2021Annual accounts 202128,6 k €↑
- 2020Annual accounts 20202,7 k €↑
- 2019Annual accounts 2019-47,6 k €↓
- 2018Annual accounts 2018-10,2 k €↓
- 2017Annual accounts 2017-3,4 k €↓
- 2016Annual accounts 201614,1 k €↓
- 2015Annual accounts 201538,7 k €↓
- 2014Annual accounts 2014483,7 k €↑
- 2013Annual accounts 2013-33,5 k €↓
- 2012Annual accounts 2012-3,4 k €↓
- 2011Annual accounts 20112,5 k €↑
- 2010Annual accounts 2010-25,3 k €
- 17/12/2009IncorporationPrivate limited company